TL;DR
Supplementing pregnant mothers with vitamin D (1000 IU/day) led to increased bone mineral density in their children at age 4, suggesting a lasting skeletal benefit. This effect was particularly pronounced in children with lower milk intake and physical activity, highlighting potential synergistic interactions.
What Problem Does This Paper Address?
The skeletal health of children is influenced by factors during pregnancy, including maternal vitamin D status. While observational studies have suggested a link between higher maternal vitamin D levels and better childhood bone development, intervention studies have been limited. The MAVIDOS trial initially found no overall effect of vitamin D supplementation on neonatal bone mass, but a secondary analysis showed a benefit for winter-born babies. This follow-up study aimed to determine if this beneficial effect on bone mass persists into early childhood (age 4) and to explore potential interactions with child's diet and activity levels.
Methods
This study is a follow-up of the MAVIDOS randomized controlled trial. Pregnant women with adequate vitamin D levels (25-100 nmol/L) were randomized to receive either 1000 IU/day of cholecalciferol (vitamin D3) or a placebo from 14 weeks of gestation until delivery. The current study focused on offspring born at the Southampton research center, assessing them at age 4. Key measurements included anthropometry (height, weight, BMI) and dual-energy X-ray absorptiometry (DXA) to assess bone mineral content (BMC), areal bone mineral density (aBMD), and bone area (BA) of the whole body less head (WBLH). Body composition (lean mass, fat mass) and grip strength were also measured. Statistical analyses included comparisons between groups, age- and sex-adjusted regression models, and hypothesis-based interaction analyses.
Datasets
The study utilized data collected from the MAVIDOS trial participants. The primary dataset for this follow-up study comprised anthropometric and DXA measurements from 452 children at age 4. Maternal characteristics and pregnancy data were also used. No new datasets were introduced.
Key Insights and Ideas
- Sustained Skeletal Benefit: The most significant finding is that maternal vitamin D supplementation during pregnancy appears to have a lasting positive impact on offspring bone mineral density, extending to at least age 4. This provides stronger evidence for a long-term benefit than the initial neonatal findings.
- Synergistic Effects: The intervention's effect on bone mineral density was amplified in children with low milk intake and low levels of physical activity. This suggests that vitamin D supplementation might be particularly crucial for children who are not receiving adequate calcium from their diet or are less physically active, as these factors also play a role in bone health.
- Lean Mass Association: Beyond bone density, there was also a trend towards increased lean mass in the supplemented group, suggesting a broader impact on musculoskeletal development.
- Season of Birth Irrelevance at Age 4: Unlike the neonatal findings, the beneficial effects on bone mass at age 4 were observed across the entire cohort, irrespective of the season of birth. This indicates that the intervention's impact may become more generalized over time.
Key Results
- Maternal vitamin D supplementation led to significantly greater WBLH aBMD in children at age 4 compared to placebo (0.477 vs. 0.470 g/cm², p = 0.048).
- Associations were consistent for BMC and lean mass, though not always statistically significant.
- The effect on aBMD was observed across the whole cohort, regardless of season of birth.
- Interactions were observed: children with low milk intake and low physical activity showed a greater effect size from maternal vitamin D supplementation.
- Child weight, height, and BMI were similar between the groups.
Limitations and Future Work
The authors acknowledge several limitations:
- Exclusion Criteria: Participants with baseline 25(OH)D levels below 25 nmol/L were excluded from the original trial, potentially limiting generalizability to populations with lower baseline vitamin D status.
- Ethnic Diversity: The study population did not include a large representation of ethnic minorities, which could affect the generalizability of findings.
- DXA Challenges: DXA assessment in children can be challenging due to movement artifacts, although the researchers employed methods to mitigate this.
- Confounding Factors: While efforts were made to control for factors like height and weight, the complex interplay of diet, physical activity, and genetics in childhood bone development is acknowledged.
- Follow-up Duration: The 4-year follow-up is a secondary analysis and does not represent the full long-term impact.
Future work includes ongoing follow-up of the MAVIDOS children to 6-8 years of age across all study centers and a planned further trial in Southampton to replicate these findings. The authors emphasize the need for further research to understand the long-term implications for fracture risk in adulthood.
Summary updated